| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $107.3M | -36.0% |
| SG&A Expense | $37.7M | -56.7% |
| Operating Income | -$152.8M | +20.1% |
| Pre-tax Income | -$136.6M | +17.5% |
| Income Tax | $442K | +149.7% |
| Net Income | -$137.1M | +17.4% |
| EPS (Basic) | -$1.91 | +18.0% |
| EPS (Diluted) | -$1.91 | +18.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.0M | +6.2% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $253.2M | -34.4% |
| Total Assets | $289.0M | -32.9% |
| Current Liabilities | $36.6M | -30.7% |
| Total Liabilities | $72.8M | -21.9% |
| Stockholders' Equity | $216.2M | -35.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$125.2M | +26.7% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $131.6M | -25.5% |
| Financing Cash Flow | -$4.3M | -4064.8% |
| Free Cash Flow | -$125.2M | +26.8% |